Kelly Hensley

发表

A central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1.

Dirk E. Smith, Randal R Ketchem, Yang-yang Huang, 2009, Immunity.

PAC1 receptor mRNA and protein distribution in rat and human trigeminal and sphenopalatine ganglia, spinal trigeminal nucleus and in dura mater

Hantao Liu, L. Edvinsson, K. Page, 2018, Cephalalgia : an international journal of headache.

CD11c/CD18: novel ligands and a role in delayed‐type hypersensitivity

S. Simon, D. Staunton, Harold J. Ting, 2007, Journal of leukocyte biology.

CD 11 c / CD 18 : novel ligands and a role in delayed-type hypersensitivity

S. Simon, D. Staunton, Harold J. Ting, 2007 .

Off-Target Platelet Activation in Macaques Unique to a Therapeutic Monoclonal Antibody

Sean P. Lear, J. Reindel, D. Rock, 2012, Toxicologic pathology.

Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways

Dirk E. Smith, J. Johnston, O. Homann, 2018, bioRxiv.

SGN-CD228A Is an Investigational CD228-Directed Antibody–Drug Conjugate with Potent Antitumor Activity across a Wide Spectrum of Preclinical Solid Tumor Models

A. Nesterova, T. Lewis, N. Okeley, 2023, Molecular cancer therapeutics.

Etelcalcetide (AMG 416), a peptide agonist of the calcium-sensing receptor, preserved cortical bone structure and bone strength in subtotal nephrectomized rats with established secondary hyperparathyroidism.

W. Richards, M. Stolina, J. Tomlinson, 2017, Bone.

Differential Expression of the Cyclic GMP-stimulated Phosphodiesterase PDE2A in Human Venous and Capillary Endothelial Cells

K. Sadhu, Kelly Hensley, S. Wolda, 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

In Vitro and in Vivo Analyses Reveal Profound Effects of Fibroblast Growth Factor 16 as a Metabolic Regulator*

W. Richards, M. Ollmann, I. Rulifson, 2016, The Journal of Biological Chemistry.

HER2-Selective and Reversible Tyrosine Kinase Inhibitor Tucatinib Potentiates the Activity of T-DM1 in Preclinical Models of HER2-positive Breast Cancer

Lauren Farr, Kelly Hensley, R. Hein, 2023, Cancer research communications.

Abstract 5581: Enfortumab vedotin, an anti-Nectin-4 ADC demonstrates bystander cell killing and immunogenic cell death anti-tumor activity mechanisms of action in urothelial cancers

A. Nesterova, T. Lewis, Bernard A. Liu, 2020 .

A central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1.

Dirk E. Smith, Randal R Ketchem, Yang-yang Huang, 2009, Immunity.

Nonclinical Safety Assessment of AMG 553, an Investigational Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Acute Myeloid Leukemia

T. Arvedson, O. Homann, H. Lebrec, 2020, Toxicological sciences : an official journal of the Society of Toxicology.

SGN-B7H4V, an investigational vedotin ADC directed to the immune checkpoint ligand B7-H4, shows promising activity in preclinical models

P. Treuting, Jason P. Schrum, E. Trueblood, 2023, Journal for ImmunoTherapy of Cancer.

Etelcalcetide, A Novel Calcimimetic, Prevents Vascular Calcification in A Rat Model of Renal Insufficiency with Secondary Hyperparathyroidism

W. Richards, M. Stolina, J. Tomlinson, 2017, Calcified Tissue International.